Executive & Institute Staff

Our team consists of passionate individuals who share the same goal to inspire health and transform care in our local, and national, community.

We work closely with members from our local health districts, our university partners and the general community to improve health through community-driven medical research.

Board of Directors

Terry Goldacre is the Managing Director of Harrington Estates (NSW) Pty Ltd, which since 1993 has been responsible for the development of the leading residential estate Harrington Park. Prior to this, he held executive positions in the civil engineering and land development industries

He is past president of the Urban Development Institute of Australia (NSW Division) and is a founding trustee of the Harrington Park Foundation.

Amanda Larkin is the Chief Executive of South Western Sydney Local Health District. Previously Amanda worked as the General Manager of Camden and Campbelltown Hospitals and the Queen Victoria Memorial Home.

Ms Larkin has a Bachelor of Social Work, Associate Diploma in Environmental Service and is working towards a Doctorate in Business Administration.

Amanda has over 25 years of experience in health service management working in the areas of community health, corporate services and acute service management in small and large health services.

Amanda currently serves as a Board member of the Ingham Institute of Applied Medical Research and the South Western Sydney Medicare Local.

She has done extensive work with management committees and boards of non-government organisations including neighbourhood centres, day care centres, short term and accommodation facilities for men and women. Her specific areas of focus are leadership, governance, patient quality and safety and health service planning and development.

Professor Annemarie Hennessy AM is the Dean and Foundation Chair of Medicine at Western Sydney University.

She was the Director of the Hypertensive Disorders of Pregnancy (HDP) Unit at the Royal Prince Alfred Women and Babies (RPAWB) from 1998 until October 2006 and continues in an honorary capacity within the unit.

Annemarie has a commitment to medical research in her capacities as Dean of the School of Medicine, WSU.
She is also the group leader of the Vascular Immunology Group at the Heart Research Institute, Director of the NHMRC Baboon Colony, Chair of the NSW University Physician Training Council and Executive Director of the PEARLS Research Group.

Annemarie is a Renal Physician with a research interest in Hypertension and Hypertension in pregnancy, which she has now been working on for 17 years.

“The broad range of research at the Ingham Institute is very exciting. Its particular strength … is the translation of its research into everyday medicine.”

— Professor Hennessy

 

Arnold Vitocco is a local Macarthur resident and licensed builder. His family’s development company, D. Vitocco Constructions Pty Ltd, has been building and developing in the Liverpool and Macarthur region since the late 1950s. Notable developments by his family company include the Narellan Town Centre and Gregory Hills, a 2,500-lot subdivision and 43 hectares of employment zone.

Arnold is a member of Narellan Chamber of Commerce and is a committee member of the St Gregory’s College, Campbelltown. He was a Board Director of the South Western Sydney Area Health Service 1997-2003 and a committee member of the Health Research Foundation Sydney South West, which successfully helped raise $8 million.

“The Ingham Institute is about medical research and the wellbeing of people. [Medical research requires] forward planning. If you plant a tree today, in 15 years you will have shade. It’s the same with medical research. We must invest in research to reap those long term rewards.”

— Arnold Vitocco

 

Jim Marsden OAM is the Senior Partner at Marsdens Law Group. His firm is based primarily at Campbelltown with offices at Liverpool, Camden and the City of Sydney.

Jim has a history in a number of areas of community involvement. His past involvement includes Chairman of West Magpie Rugby League, Wests Tigers, the Chamber of Commerce, and board membership of NSW Rugby League and Odyssey House.

Jim currently Chairs The Macarthur Club and the Macarthur Development Advisory Group based out of Campbelltown.

“Medical research is essential and exciting. I was born and raised in south-west Sydney, and the Ingham Institute gives me the opportunity to participate in the delivery of significant research outcomes in my territory.”

— Jim Marsden

 

John is a serial entrepreneur, active across diverse sectors including marketing, agriculture, property development, technology, horse breeding and racing.

After a highly successful marketing career at Ingham Enterprises, John continues to build brands as a Director of Upstart Marketing, and Chair of the Ingham Institute Marketing and Fundraising Committee.

As Director and Co-owner of Ingham Property Group, John has a strategic and governance role in the development of property assets across New South Wales, Queensland and Western Australia.

Complimenting Johns wealth of experience, horse breeding and racing is another passion for John, as Director of Ingham Racing, Rockingham Thoroughbreds and James Harron Bloodstock. Previously John held Director roles with the Australian Jockey Club and the Australian Stud Book (2008 – 2012).

A founding investor and Director of farming and livestock SAAS company Agriwebb, brings John’s heritage in food production together with his curiosity for agriculture and technology.

 “The incredible contribution that our research teams are making to the health of our local and national community, and in fact global health issues, makes me feel humble and proud.” John Ingham

Professor John Watson, AM is Senior Vice Dean, Clinical Affairs in the Faculty of Medicine at the University of NSW. Until August 2018 he was Head of the Sydney Adventist Hospital Clinical School, and Consultant Neurologist at Hornsby Ku-ring-gai, Sydney Adventist and The Mater Hospitals. Honorary Consultant Neurologist at Royal Prince Alfred Hospital. For some six years he served as Chair of the University of Sydney’s Human Research Ethics Committee, and he has served on various NHMRC subcommittees and panels.

In 2011 he established and headed Sydney Adventist Hospital Clinical School, Sydney Medical School’s newest Clinical School and the only fully-fledged clinical school in NSW operating within a private hospital setting: the first class of medical students graduated in 2015.

In 2015, Professor Watson was honoured as Member of the Order of Australia (AM) ‘for significant service to medicine in the field of neurology, to medical education and administration, and through mentoring roles.’ In 2014 he was awarded the University of Sydney MD, a higher research degree for his collected scientific work over three decades.

In recent years he has served as a Board Director in the not-for-profit sector, and has successfully completed the Australian Institute of Company Directors’ Company Directors Course and passed its examinations.

Most recently Professor Watson has been working on the concepts of Better Value Health Care, and the better preparation of students and of junior and middle stage practitioners in understanding the health services that they will part of, often for decades.

Professor Watson commenced medical studies at the University of Sydney in 1973, interrupting this course to take a BSc (First Class Honours) in Neurophysiology. He was the New South Wales Rhodes Scholar for 1977, which enabled him to travel to Oxford University for a Doctorate in Philosophy, in Neurophysiology. Returning to the University of Sydney in 1981 he completed his medical studies, again obtaining First Class Honours, before commencing work as an Intern, RMO and Registrar at Royal Prince Alfred Hospital. He then travelled to London where he was a Lecturer and Senior Registrar in Neurology at the Institute of Neurology, Queen Square and the Royal Postgraduate Medical School, Hammersmith Hospital. After a year in this position he became a Wellcome Trust Research Fellow at University College London, and the MRC Cyclotron Unit, Hammersmith Hospital. Here he undertook functional brain imaging research using Positron Emission Tomography (PET) to explore the visual system of the human brain, and the relationship between the structure and function of the human brain.

As a clinician-scientist Professor Watson’s research has focussed on three main themes: (a) the study of function and structure of the brain (predominantly the posterior brain centres including the occipital cortex and parietal cortex), using advanced brain imaging techniques; (b) methodological improvements related to these studies; (c) clinical studies that provide insight into normal and abnormal brain functions, across a wide range of human cognition. His clinical interests are behavioural neurology including dementia, focal cognitive deficits after stroke, and basic research on the human visual system.

“I consider myself a sensory physiologist interested in understanding normal and abnormal brain structure and function at a systems level, within the posterior regions of the brain, particularly relating to vision and sensory integration in the parietal lobe”.

He has used functional brain imaging such as PET and functional MRI to study visual physiology including human colour appreciation, visual motion, and edge detection. His work has resulted in major methodological contributions. He developed new methods of high-resolution magnetic resonance scanning to delineate specialised areas of human cortex in vivo. Additionally, he co-authored landmark studies identifying human brain areas critical for the detection of colour and motion, with three papers each receiving >1,000 citations. This work was instrumental in advancing knowledge of the human brain and establishing the foundations for the rapid expansion of human neuroimaging.

Karen is the General Manager of Liverpool Hospital. Karen has experience in leading teams for the planning, building and commissioning of the Fiona Stanley Hospital in Western Australia, as well as experience in implementing service delivery models, achieving activity and financial performance targets, operations management, financial accountability, emergency management and strategic planning and Population Health.

Karen is also an Australian Council of Healthcare Standards (ACHS) Surveyor.

Morris Iemma served as Premier of NSW from 2005-2008 and prior to that held the ministerial portfolios of Treasury, Health, Sport and Recreation, Public Works and Services, and Minister Assisting the Premier. During his Parliamentary career he held the seats of Hurstville and Lakemba, in the South District.

Mr Iemma is currently a board member of TAFE NSW and is Chairman of Riverwood Community Centre, Miracle Babies Foundation and NSW Cancer Institute. He has also served on the Boards of Beyond Blue, the SCG Trust and as Chair of the South East Sydney Health District.

 

Dr Teresa Anderson is the Chief Executive of the Sydney Local Health District,  providing services to more than 600,000 people in Sydney and beyond.

Dr Teresa Anderson has worked in the NSW public health system for more than 30 years and has extensive experience as a clinician, manager and health service leader. She has held positions as the Director, Clinical Operations, Sydney South West Area Health Service, General Manager, Liverpool Hospital and Director of Community and Allied Health Services for the Liverpool Health Service.

She serves on the boards of the Ingham Institute, Centenary Institute, Heart Research Institute, ANZAC Research Institute and Healthshare, and is also the Chair of the Sydney Research Council.

Dr Anderson is focused on supporting collaboration and building partnerships to provide excellent health care. She is widely acknowledged for supporting and mentoring her staff in fostering new ideas to drive efficiencies and best practice.

Tim Bryan is the Chief Executive Officer of the Perich Group and a Chartered Accountant.

He is a Founding Director and Chairman of the Finance Committee, Kids of Macarthur Health Foundation and Chairman of St Gregory’s College Finance Advisory Committee.

Tim has a special interest in research into childhood diseases.

“What excites me most … is the motivation and passion of the researchers who call Ingham Institute home.”

— Tim Bryan

 

Tony Perich AM is the Joint Managing Director of Leppington Pastoral Company, Organic Fertilisers [Leppington], the Greenfields Development Company, Arrowvest, Narellan Town Centre and Dart West Development Ltd.

Tony has an outstanding record of service within the local community having previously served as President of Narellan Rotary, Chairman of the Fundraising Committee for the Spastic Centre’s Growthpoint Project in Liverpool, Vice-President of the Narellan Chamber of Commerce and President of the Dairy Research Foundation of the University of Sydney.

In addition Tony is an ongoing member of the Urban Taskforce, the Property Council of Australia and the Urban Development Institute of Australia.

He has enormous interest in all areas of medical research and development with a particular interest in cancer research.

Wendy Hu, MBBS (Hons, University Medal), GradDipPaed, MHA, PhD, FRACGP is Professor of Medical Education and Associate Director, Learning & Innovation at the School of Medicine, Western Sydney University and Honorary Medical Officer, Sydney Children’s Hospital Network. After a career in paediatric primary care, clinical research and medical administration, Wendy became a medical educator. She serves as an accreditor of medical schools and programs for the Australian Medical Council, HETI NSW and Ministry of Education, China, on the Editorial Boards for three international research journals, the Academic Standards and Education Committees for postgraduate training bodies, and chairs the Australian and New Zealand group overseeing the undergraduate medical school entrance test. Wendy leads national and international research and education collaborations aimed at building evidence and impact from quality education and training on patient care and health outcomes, in partnership with communities and health services.

“You know a good doctor, nurse and allied health practitioner when you meet one, but how are they created?”

– Wendy Hu

Careers and Education

You can contact Grace on 02 8738 9000 or grace.micali@inghaminstitute.org.au

Executive Staff

Darryl Harkness joined the Ingham Institute after nearly 30 years with Johnson & Johnson, most recently as Vice President of Orthopaedics and Neurosurgery and member of the Johnson & Johnson Medical Australia & New Zealand Board.  During his career Darryl had a number of overseas postings which included leading the Ortho Clinical Diagnostics businesses in Asia Pacific and being a member of their Global Management Board.

His business experience also includes leadership of Johnson & Johnson companies working in bariatrics, minimally invasive surgery, low temperature sterilisation, hand hygiene and cardiology.  These diverse roles provided many opportunities to work with leading clinicians as new technologies were developed, evaluated and eventually made available to treat patients.

Darryl served two terms on the Board of the Medical Technology Association of Australia including one term as Treasurer.  He was fortunate to be involved in many of Johnson & Johnson’s community initiatives and served as chair of their Diversity & Inclusion Council.

“Its hard to imagine anything more important than improving people’s health.  The work being done by the gifted and dedicated researchers at the Ingham Institute is nothing short of amazing and it is a tremendous privilege to be playing a role supporting them”

You can contact Darryl on 02 8738 9000 or darryl.harkness@inghaminstitute.org.au

Professor Les Bokey  AM., M.S., F. R.A.C.S., F.R.C.S.  (Glas.) (Hon.) is Foundation Professor of Surgery and Clinical Dean, Western Sydney University at Liverpool Hospital.  He is the Director of Research for the South Western Sydney Local Health District, Institute Director at The Ingham Institute for Applied Medical Research amd Director of Surgery at Liverpool Hospital. His research interests include screening, and early diagnosis of bowel cancer, outcomes after surgery for bowel cancer, inflammatory bowel disease, robotics and automation in health.  He is the Director of The South Western Institute for Robotics and Automation in Health (SWIRAH).  His expertise and technical innovations, especially in rectal cancer surgery, are acknowledged internationally.

Professor Bokey has worked at St. Bartholomew’s Hospital, London, Sahlgrenska University Hospital, Goteborg and the Cleveland Clinic Foundation.  Before joining Western Sydney University, he was Head of Surgery, Faculty of Medicine and Associate Dean of Surgical Sciences at Sydney University.

In 2016, he was appointed Interim Director of ‘Maridulu Budyari Gumal’ The Sydney Partnership for Health, Education, Research & Enterprise (SPHERE) and was instrumental in fostering clinical academic groups across the partnership which subsequently led to NHMRC AHRTC accreditation of SPHERE.

He has been awarded The Order of Australia Medal for service to medicine as colorectal surgeon and establishment of surgical education programs, research, and medical administration. He has received several honorary degrees from various International Universities and Societies.

Associate Professor Greg Kaplan has a strong background in research, research management, administration and governance. He obtained a PhD in Medical Physics from the University of Wollongong in 2002 and is now completing MBA from the University of Tasmania.

Greg Kaplan has been the Ingham Institute’s Chief Operating Officer and Company Secretary since 2010. He was appointed by the Board of Directors as the first employee and was responsible for overseeing the construction and set-up of the Ingham Institute. Greg puts a special significance on the translation of research into practice and nurturing close cooperation with universities, hospitals and industry. He is passionate about engagement and promotion of medical research with local communities.

You can contact Greg on 02 8738 9119 or greg.kaplan@inghaminstitute.org.au

Fundraising and Marketing

You can contact David on 0450 019 189  or david.stewart@inghaminstitute.org.au

Ingham Institute Research Leadership Committee

Professor Apte is internationally acknowledged as a leading researcher in the fields of alcohol-induced pancreatic injury, pancreatic fibrogenesis and stromal-tumour interactions in pancreatic cancer.

Professor of Medicine and Director, Pancreatic Research Group, UNSW Sydney

An internationally renowned medical researcher into pancreatic disease, Professor Minoti Apte’s contribution to the University of New South Wales and the wider community extends well beyond her laboratory. In 2014, she was awarded a Medal of the Order of Australia and she received the 2015 NSW Premier’s Award for Woman of the Year, in recognition of her contribution to medical research, tertiary education and the community. Most recently, her work in pancreatic cancer research was recognised with the Professor Rob Sutherland Make a Difference Award presented at part of the Cancer Institute NSW 2016 Premier’s Awards for Outstanding Cancer Research. In 2017, she was awarded the Lady Mary Fairfax Distinguished researcher Award by the Ingham Institute.

A Professor of Medicine and Director of the Pancreatic Research Group at UNSW, Prof Apte is internationally acknowledged as a leading researcher in the field of pancreatic injury and is particularly recognised for her pioneering work in pancreatic fibrogenesis, having been the first in the world to develop a method to isolate and culture pancreatic stellate cells (PSCs).

Her Group was the first in the world to establish the role of these cells in the scar tissue of chronic pancreatitis and pancreatic cancer. This scar tissue is responsible for significant pancreatic dysfunction and for cancer progression. Her group was also the first in the world to show that the pancreatic stellate cell helped pancreatic cancers grow and spread, and she is currently leading pre-clinical studies of a new combination therapy to help improve treatment outcomes. Professor has published over 120 research papers, and her work has received over 6400 citations. She is currently the Editor-in-Chief of Pancreatology, one of the two leading specialist journals in the field.

Professor Apte served as postgraduate coordinator within the South Western Sydney Clinical School from 2001-2016, where she nurtured the talent of our PhD, Masters and Honours students, in addition to direct supervision of her own higher degree students. She has served/serves at senior levels on several key committees within the University as well as on committees of national and international organisations relevant to her Discipline, including the GESA Research Committee.

In addition to her role within UNSW Medicine and the wider discipline of Pancreatology, Professor Apte is an active member of the Marathi Association of Sydney, which serves Sydney’s large Indian population. She is an accomplished Indian classical dancer and choreographer, and has served on the Association’s organising committee, provided programs for community radio, plays an active role organising and performing in cultural events and provides mentorship and career advice to new migrants in her community.

Professor Nick Shackel leads the Gastroenterology and Liver Laboratory at the Ingham Institute and Liverpool Hospital. He is a Professor of Medicine and Gastroenterology at the University of New South Wales, a Senior Clinician within the Department of Gastroenterology and Liver at Liverpool Hospital, a PhD Scientist and Liver Researcher. Prof Shackel leads a program in functional genomics to better understand cirrhosis and liver cancer, as well as using transgenic animals to model human liver disease. Clinical research undertaken by his group examines the side effects of check-point inhibitors, microbiome relationship to liver disease severity, treatment of cramps, predictors of liver injury and nutritional interventions in end stage liver disease.

The research Prof Shackel has led has made a number of highly significant and novel discoveries in liver disease including

  • The first gene array identification of a distinct immune phenotype (Th1) in hepatitis C virus associated liver injury
  • The initial identification of the development associated WNT and Hedgehog pathway in human adult liver disease
  • The initial description of a novel mechanism of inflammation mediated by the glycoprotein basigin (aka. CD147)
  • Describing the passenger mutational profile of liver cancer

Prof Shackel is an Australia Liver Association and a Transplant Society of Australia and New Zealand council member. He has helped draft national policy in areas as diverse as the utilisation of potentially infectious organ donors for transplantation and the ethics of tissue utilisation in research. Prof Shackel balances his clinical commitments with supervision of the laboratory, directing research ranging from next generation sequencing to understanding the effects of nutritional interventions in cirrhosis. He is a regular National Health and Medical Research Council (NHMRC) panel member, reviewer for multiple journals and has collaborations in Europe and North America. Prof Shackel demonstrates an active commitment to teaching of all students from undergraduates through to RACP exam candidates and mentors many young researchers.

Evelyne de Leeuw joined CHETRE in September, 2015, and is based at the interface of health research, policy and practice at UNSW Australia, the South Western Sydney Local Health District/Population Health, and the Ingham Institute. She currently is also the Director of the HUE (Healthy Urban Environments) Collaboratory, a Maridulu Budyari Gumal SPHERE CAG, run by three universities (UNSW, UTS and WSU) and two LHDs (South Eastern and South Western Sydney).

Professor de Leeuw holds a Masters in Health Policy and Administration (University of Maastricht, The Netherlands, 1985), MPH at the University of California at Berkeley in comparative health systems research (1986) and a PhD in health political science (Maastricht, 1989).

Since its initiation in 1986, she has been active in the international Healthy Cities movement. From 1992 to 2001 she held the position of Director of the World Health Organization Collaborating Centre for Research on Healthy Cities at the University of Maastricht. She assists WHO regionally and globally in Healthy City evaluation reporting, most recently in special issues of Health Promotion International and the Journal of Urban Health. She is known for her strong engagement with local health policies and politics and is a welcome speaker at both community and research events.

Professor de Leeuw has a reputation in building public health curricula in tertiary education around the world, establishing Schools of Public Health in The Netherlands, Denmark, advising such endeavours in Kazakhstan, Estonia and El Salvador, and negotiating a world class public health programme in the Medical School at Deakin University (Geelong, Australia).

She has been involved in WHO health promotion endeavours since the 1986 Ottawa Conference and attended all subsequent international health promotion conferences; at the fourth one (Jakarta, 1997) and eight one (Helsinki, 2013) she acted as conference rapporteur.

Evelyne currently holds appointments as Visiting Professor, Université de Montréal; and Visiting Professor, Maastricht University (The Netherlands). She is WHO European Research Director for Healthy Cities. She was a member of global scientific committees of the 2019 and 2020 IUHPE and Healthy Cities conferences and member of the IUHPE Executive Board. She is currently the Chair of the Global Scientific Committee of IUHPE2022.

Evelyne is Editor-in-Chief of the international peer-reviewed journal Health Promotion International and considered a leading global health promotion scholar, as evidenced by her appointments to high-level research panels (e.g., the Academy of Finland, and Science Ministries in Japan and Germany). She edits the Palgrave Series on health political science.

She has published several books (notably on Healthy Cities with WHO, and Springer; on policy approaches to health promotion with Oxford University Press; on consumer health democratisation with Edward Elgar) and over 120 peer-reviewed articles, plus several dozen book chapters. Her scholarship and writing focus on (1) methodologies for complex local health evaluations; (2) policy and governance for health innovation at the local level; and (3) action at the nexus between research, policy and practice.

In the latter area, her conceptual framework (‘nexus theories’) is used by health and medical research councils in The Netherlands, Germany and Canada to frame and assess calls for research proposals.

Though based in Australia with an admittedly Oceanic/Pacific ‘service area’, Professor de Leeuw happily considers the world her oyster. She is an enthusiastic user of social media like twitter, blogging and Vimeo.

Lois Holloway leads the medical physics group at the Ingham Institute and Liverpool and Macarthur Cancer Therapy centres. She has a long interest in mathematical modelling for radiotherapy and is excited by ongoing developments and opportunities in both imaging and machine learning in this area. She leads the OzCAT (Computer Assisted Theragnostics) working to link distributed datasets to develop prognostic models for radiotherapy, particularly for situations where randomised clinical trial evidence is limited.

Professor C. Soon Lee, MBBS (Melb), MD (Melb), FRCPA, FRCPath (UK), MIAC, AFRACMA

Prof Lee is the Foundation Professor and Chair of Pathology at Western Sydney University. He is also Clinical Professor at University of Sydney, Conjoint Professor at University of New South Wales, and Senior Pathologist at Liverpool Hospital and Royal Prince Alfred Hospital.

Prof Lee is a certified pathologist for genomics testing and heads the Molecular Pathology Service at Liverpool Hospital that provides diagnostic molecular testing for patients from Sydney South West Local Health District, St George and Wollongong Hospitals.

Prof Lee’s research interests include genomics and biomarkers of colorectal, lung and head and neck cancers. He heads the Cancer Pathology and Cell Biology Laboratory, Ingham Institute. His research group has made significant contributions that have influenced and led to changes in the clinical practice of pathology including the detection of EGFR and HPV in head and neck cancers, detection of the human herpes virus 8 in the diagnosis of early stage Kaposi’s sarcoma, and the use of the EWS/FLI1 fusion transcript in the diagnosis of Ewing’s sarcoma.

He has published over 210 original research articles in international peer-reviewed journals with over 8,400 citations for his publications; and an H-index of 53. Professor Lee has mentored and graduated over 20 higher degree students, many of whom have gone on to forge successful careers as Professors, Associate Professors and Heads of Departments.

Prof Lee was the recipient of the 2017 Lady Mary Fairfax Distinguished Researcher Award and the 2018 Distinguished Pathologist Award of the International Academy of Pathology. He was previous Editor of the journal, Pathology (2000-2009) and Editor-in-Chief of the Journal of Clinical Pathology (2010-2016). He holds international appointments as the Distinguished Visiting Scholar at the Graduate Medical School, Duke University-National University of Singapore (since 2015) and Visiting Professor and International Advisor at Sunway University in Malaysia (since 2017).

Darryl Harkness joined the Ingham Institute after nearly 30 years with Johnson & Johnson, most recently as Vice President of Orthopaedics and Neurosurgery and member of the Johnson & Johnson Medical Australia & New Zealand Board.  During his career Darryl had a number of overseas postings which included leading the Ortho Clinical Diagnostics businesses in Asia Pacific and being a member of their Global Management Board.

His business experience also includes leadership of Johnson & Johnson companies working in bariatrics, minimally invasive surgery, low temperature sterilisation, hand hygiene and cardiology.  These diverse roles provided many opportunities to work with leading clinicians as new technologies were developed, evaluated and eventually made available to treat patients.

Darryl served two terms on the Board of the Medical Technology Association of Australia including one term as Treasurer.  He was fortunate to be involved in many of Johnson & Johnson’s community initiatives and served as chair of their Diversity & Inclusion Council.

“Its hard to imagine anything more important than improving people’s health.  The work being done by the gifted and dedicated researchers at the Ingham Institute is nothing short of amazing and it is a tremendous privilege to be playing a role supporting them”

You can contact Darryl on 02 8738 9000 or darryl.harkness@inghaminstitute.org.au

Professor Les Bokey  AM., M.S., F. R.A.C.S., F.R.C.S.  (Glas.) (Hon.) is Foundation Professor of Surgery and Clinical Dean, Western Sydney University at Liverpool Hospital.  He is the Director of Research for the South Western Sydney Local Health District, Institute Director at The Ingham Institute for Applied Medical Research amd Director of Surgery at Liverpool Hospital. His research interests include screening, and early diagnosis of bowel cancer, outcomes after surgery for bowel cancer, inflammatory bowel disease, robotics and automation in health.  He is the Director of The South Western Institute for Robotics and Automation in Health (SWIRAH).  His expertise and technical innovations, especially in rectal cancer surgery, are acknowledged internationally.

Professor Bokey has worked at St. Bartholomew’s Hospital, London, Sahlgrenska University Hospital, Goteborg and the Cleveland Clinic Foundation.  Before joining Western Sydney University, he was Head of Surgery, Faculty of Medicine and Associate Dean of Surgical Sciences at Sydney University.

In 2016, he was appointed Interim Director of ‘Maridulu Budyari Gumal’ The Sydney Partnership for Health, Education, Research & Enterprise (SPHERE) and was instrumental in fostering clinical academic groups across the partnership which subsequently led to NHMRC AHRTC accreditation of SPHERE.

He has been awarded The Order of Australia Medal for service to medicine as colorectal surgeon and establishment of surgical education programs, research, and medical administration. He has received several honorary degrees from various International Universities and Societies.

Associate Professor Greg Kaplan has a strong background in research, research management, administration and governance. He obtained a PhD in Medical Physics from the University of Wollongong in 2002 and is now completing MBA from the University of Tasmania.

Greg Kaplan has been the Ingham Institute’s Chief Operating Officer and Company Secretary since 2010. He was appointed by the Board of Directors as the first employee and was responsible for overseeing the construction and set-up of the Ingham Institute. Greg puts a special significance on the translation of research into practice and nurturing close cooperation with universities, hospitals and industry. He is passionate about engagement and promotion of medical research with local communities.

You can contact Greg on 02 8738 9119 or greg.kaplan@inghaminstitute.org.au

Research Support Staff